MedImmune Turns To Venture Philanthropy For Cancer ImmunoRx Combination Trials

MedImmune and two non-profit research organizations are collaborating on clinical trials that explore the tricky world of combinations of novel cancer immunotherapies, including three MedImmune compounds in different stages of development.